CN Stock MarketDetailed Quotes

002399 Shenzhen Hepalink Pharmaceutical Group

Watchlist

10.19
-0.09-0.88%

Not Open Jan 21 15:00 CST

14.95BMarket Cap-101.90P/E (TTM)

Shenzhen Hepalink Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shenzhen Hepalink Pharmaceutical Group Q4 2024 Estimates Date

Currency：HKDMar 29, 2025

	Estimate	YoY
Revenue	1.43B	-4.88%
EPS	0.02	+103.07%

Analyst Rating

Buy

Jan 21, 2025

Shenzhen Hepalink Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2020/Q4	1.790B / --	--
--	2020/Q3	883.279M / --	--
--	2020/Q2	1.257B / --	--
--	2020/Q1	1.402B / --	--

DatePeriodRevenue/EstimateEarnings Call

--2020/Q41.790B / ----

--2020/Q3883.279M / ----

--2020/Q21.257B / ----

--2020/Q11.402B / ----

--------

Unlock Free Earnings Estimates

Open Account

Shenzhen Hepalink Pharmaceutical Group Earnings Reports

Highpree: Third quarter 2024 report

Oct 30, 2024 12:00 ET

Highpree: 2024 Semi-Annual Report

Aug 30, 2024 12:00 ET

Highpree: 2024 Semi-Annual Report Summary

Aug 30, 2024 12:00 ET

Shenzhen Hepalink Pharmaceutical Group: 2024 Interim Performance Forecast

Jul 12, 2024 12:00 ET

Symbol Price % Chg

Anhui Bossco Environmental Protection Technology

300422

5.32 +20.09%

MH Robot & Automation

301199

35.99 +20.01%

Shanghai Hajime Advanced Material Technology

See the daily top gainer.

Analysis

Analyst Rating

Updated: Jan 21, 2025

Buy

Strong Buy
0.00%
Buy
100.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Shenzhen Special Zone

Intraday+0.89%

Monoclonal Antibody Concept

Intraday+0.53%

Shenzhen Stock Exchange

Intraday+0.28%